v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
 12 Months Ended 182 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
OPERATING ACTIVITIES      
Net loss $ (2,997,229) $ (8,328,660) $ (48,857,954)
Depreciation     52,694
Stock-based compensation-product development 5,996 1,749 536,363
Stock-based compensation-interest expenses   5,377,907 13,330,984
Stock-based compensation-selling, general and admin 65,958 197,017 3,486,791
Stock-based compensation-professional fees 172,959   217,774
Stock-based compensation-market development   20,989 20,989
Other non-cash items included in net loss     341,629
Unpaid Interest expense on line of credit 578,039 406,732 1,232,944
Non-cash imputed interest expenses 183,988 169,248 3,351,064
Equity instruments issued to settle liabilities     1,871,718
Changes in assets and liabilities:      
Decrease in prepaid expenses 12,441 (13,217) (4,388)
Increase in accounts payable and accrued liabilities 64,224 134,214 1,570,163
Increase in advances payable   5,086 3,152,071
Increase in interest payable 505,696 499,041 4,738,007
Increase in other working capital balances     8,727
Cash used in operating activities (1,407,928) (1,529,894) (14,950,424)
INVESTING ACTIVITIES      
Purchase of equipment     (43,078)
Cash used in investing activities     (43,078)
FINANCING ACTIVITIES      
Other financing activities     (115,472)
Expenditures to repurchase shares     (342,038)
Proceeds from issuance of shares     1,512,403
Repayment of promissory notes payable     (970,879)
Proceeds from issuance of promissory notes     9,418,676
Proceeds from lines of credit 1,426,404 1,529,974 5,520,370
Net cash provided by financing activities 1,426,404 1,529,974 15,023,060
Net increase in cash 18,476 80 29,558
Cash, beginning of period 11,082 11,002  
Cash, end of period 29,558 11,082 29,558
Supplemental cash flow information:      
Interest expense incurred in connection with options granted in exchange for increase in borrowing limit on existing line of credit financing   5,377,907  
Options exercised for reduction in accounts payable 60,000    
Options exercised for reduction in interest payable $ 30,000 $ 1,075,000